Black Diamond Therapeutics, Inc. Stock
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 2.030 USD | +2.53% |
|
-4.25% | -16.46% |
| Market Cap | 114M 98.57M 93.02M 84.39M 158M 10.9B 159M 1.11B 428M 5.53B 427M 418M 17.58B | P/E 2026 * |
-3.29x | P/E 2027 * | -2.13x |
|---|---|---|---|---|---|
| Enterprise Value | 114M 98.57M 93.02M 84.39M 158M 10.9B 159M 1.11B 428M 5.53B 427M 418M 17.58B | EV / Sales 2026 * |
18.2x | EV / Sales 2027 * | - |
| Free-Float |
99.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BDTX | Delayed | |
CBOE
| BDTX | Real-time |
| 1 day | +2.53% | ||
| 1 week | -4.25% | ||
| Current month | -3.33% | ||
| 1 month | +0.50% | ||
| 3 months | +16.00% | ||
| 6 months | -4.25% | ||
| Current year | -16.46% |
| 1 week | 1.92 |  | 2.15 |
| 1 month | 1.92 | | 2.32 |
| Current year | 1.6 | | 3.97 |
| 1 year | 1.6 | | 4.94 |
| 3 years | 1.2 | | 7.66 |
| 5 years | 1.18 | | 10.07 |
| 10 years | 1.18 | | 46.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Velleca
CEO | Chief Executive Officer | 62 | 2023-09-15 |
Elizabeth Buck
CTO | Chief Tech/Sci/R&D Officer | 51 | 2021-08-10 |
Erika Jones
DFI | Director of Finance/CFO | 41 | 2024-10-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Garry Menzel
BRD | Director/Board Member | 61 | 2017-02-28 |
Samarth Kulkarni
BRD | Director/Board Member | 47 | 2019-11-30 |
Ali Behbahani
BRD | Director/Board Member | 49 | 2018-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/20/26 | NEA Management Co. LLC
| Other | Company | 0 | 0% | - |
| 3/20/26 | Free | Director | 6,105 | 0.0107% | ||
| 3/20/26 | Free | Director | 6,919 | 0.0121% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.53% | -4.25% | -37.54% | -43.61% | 114M | |
| +5.04% | +3.27% | +50.62% | +105.43% | 66.93B | |
| +1.64% | -0.18% | +34.67% | +76.81% | 61.97B | |
| -3.18% | -0.78% | -14.14% | +369.82% | 28.26B | |
| +4.55% | -0.08% | +34.70% | +17.28% | 24.59B | |
| +2.20% | -4.72% | +2.19% | -13.14% | 24.3B | |
| +1.15% | -2.26% | +17.56% | -16.53% | 19.41B | |
| -7.03% | -9.16% | +161.91% | +303.00% | 16.77B | |
| +3.44% | -1.68% | -5.00% | +541.17% | 14.18B | |
| +4.96% | +4.63% | -2.75% | +864.40% | 14B | |
| Average | +1.53% | -4.21% | +24.22% | +220.46% | 27.05B | |
| Weighted average by Cap. | +1.99% | -2.84% | +33.22% | +173.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.25M 5.42M 5.11M 4.64M 8.7M 599M 8.76M 61.04M 23.52M 304M 23.47M 22.96M 966M | - |
| Net income | -36.96M -32.03M -30.23M -27.42M -51.44M -3.54B -51.81M -361M -139M -1.8B -139M -136M -5.71B | -64.65M -56.02M -52.86M -47.96M -89.97M -6.2B -90.62M -631M -243M -3.14B -243M -237M -9.99B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | US$2.030 | +2.53% | 514,156 |
| 26-09-11 | US$1.980 | +1.02% | 590,205 |
| 26-09-10 | US$1.960 | -6.67% | 677,922 |
| 26-09-09 | US$2.100 | 0.00% | 402,592 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BDTX Stock
Select your edition
All financial news and data tailored to specific country editions
